A small clinical trial of a novel antidepressant that stimulates neurogenesis — the production of new brain cells — shows that the compound appears to be safe and may be effective against depression.
A small clinical trial of a novel antidepressant that stimulates neurogenesis — the production of new brain cells — shows that the compound appears to be safe and may be effective against depression.